GLP-1 Dosage Chart and Personalized Treatment Overview

Why Dosage Isn’t One-Size-Fits-All

GLP-1 therapy involves more than just dosage numbers; it's a personalized medical decision. Licensed healthcare providers consider multiple factors before determining your dosage or titration plan, including:

• Treatment objectives (e.g., glycemic control, weight management, appetite regulation)
  
• Existing health conditions such as type 2 diabetes, polycystic ovary syndrome (PCOS), or cardiovascular issues
  
• Allergies or sensitivities to medication components
  
• Potential side effects like nausea or gastrointestinal discomfort
  
• Individual tolerance to dosage escalations over time
  
  

Licensed healthcare providers may recommend a titration schedule that deviates from standard protocols and may customize formulations with supportive additives to manage side effects based on each individual.

‍

Sample GLP-1 Titration Chart (For Educational Purposes Only)

This chart illustrates a generalized dose escalation path commonly used with semaglutide. Actual dosage should be determined by a licensed healthcare provider and may vary from individual to individual as determined by a licensed healthcare provider

‍

‍

Note: The 0.25 mg dose may be used to initiate therapy and is not intended for glycemic control. (Drugs.com)

‍

Understanding Brand-Name GLP-1 Options

Brand-Name Medications: Products such as Ozempic® and Wegovy® are FDA-approved and manufactured under strict quality and safety standards. Ozempic® is approved only for the treatment of type 2 diabetes, and Wegovy® is approved for chronic weight management in patients who meet specific FDA-defined criteria.

Eden does not manufacture, prescribe, or dispense medications. Licensed healthcare providers make All prescribing decisions independently following a comprehensive review of your medical history, current health status, and individual clinical needs.

‍

What to Expect During Your Treatment Journey

Your experience with GLP-1 therapy may include three key phases, determined and monitored by a licensed healthcare provider:

Initial Dosing (Weeks 1–4): Treatment typically begins with a lower dose, which may support tolerability and allow the body time to adapt.

Titration Phase (Weeks 5–12): Dosage may be gradually increased through a shared decision between you and your licensed healthcare provider, based on your individual tolerance, response to therapy, and clinical monitoring.

Maintenance Phase (Month 3 and beyond): Your licensed healthcare provider will determine your optimal dose based on your ongoing response to treatment and will continue to monitor and adjust your plan as clinically appropriate.

Eden’s Role in Personalized GLP-1 Care

Eden is a digital health platform dedicated to facilitating access to licensed medical care. Our mission includes:

• Providing clear, accessible education about GLP-1 medication options and how they may support metabolic health.
  
• Connecting you with licensed healthcare providers who may prescribe GLP-1 medications, when clinically appropriate, based on individual health.
  
• Coordinating access to prescribed medications through licensed U.S. pharmacies, if prescribed.
  
  

Disclaimer: 

Eden does not practice medicine, prescribe, or dispense medications. All clinical care and prescribing decisions are made independently by licensed healthcare providers. Eden’s role is to provide educational resources and help facilitate access to care when appropriate.

‍